AI-assisted, source-referenced information. Independent clinical review is pending. Our standards.
The short answer

Seek care according to the symptom, even if you are unsure whether a medicine caused it. Do not wait for a routine provider message when symptoms are severe or rapidly worsening.

Breathing difficulty or collapse is an emergency

Call 999 if there is sudden swelling of the mouth, tongue or throat, difficulty breathing, or collapse suggesting a serious allergic reaction. If you have a prescribed adrenaline auto-injector, follow your emergency instructions. Do not treat an online consultation form as an emergency service.

When another person is unwell, tell the call handler what is happening and follow their instructions. Keep the medicine packaging available if it can be obtained without delaying care. The priority is emergency assessment; proving that a dose caused the reaction is not something you need to do first.

Sources: NHS: Anaphylaxis: emergency symptoms and action

Severe persistent abdominal pain needs prompt assessment

GLP-1-related pancreatitis warnings describe severe, persistent abdominal pain, sometimes spreading to the back, with or without nausea or vomiting. Seek urgent medical attention. Sudden severe tummy pain or pain with vomiting, jaundice or a high temperature can also need emergency assessment. Do not dismiss these features as routine digestive side effects.

Tell the clinician the medicine name, strength and last dose date, including privately prescribed treatment that may not appear on the GP record. They will decide what investigations and treatment are needed. If pancreatitis is confirmed, do not restart the GLP-1 treatment; follow the treating clinician's plan for ongoing care.

Sources: MHRA: GLP-1 medicines: strengthened warnings on acute pancreatitis; NHS: Gallstones: symptoms and urgent help

Sudden vision loss should not wait

The MHRA advises urgent eye casualty or A&E assessment for sudden loss of vision in someone using semaglutide, especially when one eye is affected. NAION is recognised as a very rare adverse effect. A clinician must assess the cause, and other eye problems can also need urgent treatment.

Do not drive yourself with a new vision problem. Tell the assessing team about diabetes, previous eye disease and all medicines. Do not wait to see whether changing the next dose fixes the problem. The urgency comes from the symptom, not from certainty about which condition is responsible.

Sources: MHRA: MHRA updates semaglutide guidance on very rare NAION; NHS: Semaglutide: uses, side effects and precautions

Repeated vomiting and low glucose need their own plans

Seek prompt advice if vomiting or diarrhoea prevents drinking normally. Reduced urine, persistent dizziness on standing, a fast heartbeat or unusual drowsiness can indicate significant dehydration. People with kidney disease or fluid restrictions need individual advice rather than a standard internet fluid target.

If you have diabetes and use insulin or medicines such as sulfonylureas, follow your agreed hypoglycaemia plan for shaking, sweating, confusion or a low glucose reading. If someone is unconscious, do not give food or drink. Call 999 when they are not responding normally and emergency treatment is unavailable or not working, following NHS guidance.

Sources: NHS: Dehydration: symptoms and when to get help; NHS: Low blood sugar: hypoglycaemia

Make sure the prescriber receives the outcome

After urgent care, share the assessment and discharge instructions with the clinician responsible for your prescription. Confirm what to do about the next scheduled dose and whether follow-up tests or appointments are needed. A different clinician may have treated the immediate problem without having access to your full prescribing history.

Suspected side effects can also be reported through the MHRA Yellow Card scheme. Record the brand, strength, dates and other medicines. A Yellow Card report supports safety monitoring and is separate from seeking treatment. Keep both the care plan and the reporting task clear.

Sources: MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know

Questions, answered.

Do I need to know that the medicine caused the symptom before seeking help?

No. Serious symptoms need assessment regardless of their cause. Tell clinicians about the medicine so they can consider it.

Sources: MHRA: GLP-1 medicines: strengthened warnings on acute pancreatitis; NHS: Anaphylaxis: emergency symptoms and action

Can a Yellow Card report replace a consultation?

No. It is a safety-reporting system, not an urgent clinical advice service.

Sources: MHRA: GLP-1 medicines for weight loss and diabetes: what you need to know

Sources & further reading

Original sources for this guide. Source checks are not independent clinical review.

  1. Anaphylaxis: emergency symptoms and actionNHS · Accessed 19 November 2026
  2. GLP-1 medicines: strengthened warnings on acute pancreatitisMHRA · Accessed 19 November 2026
  3. Gallstones: symptoms and urgent helpNHS · Accessed 19 November 2026
  4. MHRA updates semaglutide guidance on very rare NAIONMHRA · Accessed 19 November 2026
  5. Semaglutide: uses, side effects and precautionsNHS · Accessed 19 November 2026
  6. Dehydration: symptoms and when to get helpNHS · Accessed 19 November 2026
  7. Low blood sugar: hypoglycaemiaNHS · Accessed 19 November 2026
  8. GLP-1 medicines for weight loss and diabetes: what you need to knowMHRA · Accessed 19 November 2026